Mylan NV said it is the first company to offer an innovative, reduced-dose HIV treatment in India.
Mylan (Nasdaq:MYL) subsidiary Mylan Pharmaceuticals Private Limited has received marketing authorization from the Drug Controller General of India for its antiretroviral drug Avonza. The fixed-dose combination comprised of Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets is recommended by the World Health Organization as an alternative first-line regimen for people being treated for…
Mylan NV said it is the first company to offer an innovative, reduced-dose HIV treatment in India.
Mylan (Nasdaq:MYL) subsidiary Mylan Pharmaceuticals Private Limited has received marketing authorization from the Drug Controller General of India for its antiretroviral drug Avonza. The fixed-dose combination comprised of Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets is recommended by the World Health Organization as an alternative first-line regimen for people being treated for…